ClinicalTrials.Veeva

Menu

Low Level Laser Therapy Versus Pharmacotherapy in in Improving Masticatory Muscle Pain

S

Shahid Beheshti University

Status and phase

Unknown
Phase 1

Conditions

TMD

Treatments

Radiation: low level laser therapy
Drug: Naproxen

Study type

Interventional

Funder types

Other

Identifiers

NCT01659372
ABT-1233-RV

Details and patient eligibility

About

tempromandibuar disorders are a group of heterogenous pathologies affecting temporomandibular joint,muscles or both.in more than 90%of cases muscles are the origin of pain.TMDs cause pain,movement disability and deficit in quality of life.in more than 90%of cases pain is the major complaint.we run this investigation to find the analgesic effct of low level laser therapy versus pharmacotherapy with naproxen in improving pain.

Enrollment

40 estimated patients

Sex

All

Ages

15 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • patients with TMD affecting masticatory muscles

Exclusion criteria

  • systemic disease
  • GI problem
  • pregnancy
  • epidermal cancer

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

40 participants in 2 patient groups

Low level laser therapy
Experimental group
Description:
this arm recieves low level laser therapy treatment for 12 sessions.
Treatment:
Radiation: low level laser therapy
naproxen
Experimental group
Description:
this arm takes naproxen 500 mg twice daily for 3weeks
Treatment:
Drug: Naproxen

Trial contacts and locations

1

Loading...

Central trial contact

saranaz azari marhabi, post graduate student

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems